Ascend Wellness Holdings, Inc. (OTCQX:AAWH) Q2 2025 Earnings Conference Call August 7, 2025 5:00 PM ET Company Participants Francis Perullo - Co-Founder, President & Director Roman Nemchenko - CFO, Executive VP & Chief Accounting Officer Samuel Brill - CEO & Director Conference Call Participants Brenna Cunnington - Unidentified Company Operator Good afternoon, ladies and gentlemen, and welcome to the Ascend Wellness Holdings, Inc. Second Quarter 2025 Earnings Conference Call. [Operator Instructions] This call is being recorded on Thursday, August 7, 2025.
Ascend Wellness Holdings, Inc. (AAWH) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to a loss of $0.1 per share a year ago.
Many people today have a fear of marijuana stocks. However, there is more to the picture, and the potential exists for a full recovery in the sector. For a long time, there has been significant volatility among most publicly traded cannabis companies. Often resulting in short pops that lead to quick downtrends with no sustainability. Now is the time to buy and hold, or figure out other investment possibilities? For some, they see it as a future investment that has the potential to yield big gains when the moment is right.
Although the cannabis industry dropped in overall projections, companies are still showing success in some areas. This gives some people hope that marijuana stocks will ultimately see a correction. For a long time, the volatile downtrend for most marijuana stocks has been brutal. Even with some small moments of upward trading, the time in which a certain pot stock hits a higher price, it's already dropped back down.
The U.S. cannabis market continues to show strong growth, with sales reaching approximately $38.5 billion in 2024. Analysts expect this figure to exceed $44 billion in 2025. The industry supports over 440,000 full-time jobs and remains one of the fastest-growing sectors in the country. Demand continues rising in both medical and adult-use markets, especially in newly legalized states. This week, several marijuana stocks are showing strength, especially companies with strong U.S. footprints and improving financials. Names like AYR Wellness, Ascend Wellness, and Glass House Brands are gaining investor attention. Their operations span high-growth states with favorable cannabis laws. However, due to sector volatility, using technical analysis is key. Traders are watching support levels, trendlines, and breakouts to time entries. Additionally, risk management must be a top priority. Limiting position sizes and setting tight stop-loss levels help protect capital while allowing for upside exposure.
The cannabis industry has experienced tremendous growth. Despite the continuous ups and downs, most cannabis companies in the US have been able to show solid revenue with recent earnings. Now some companies could have done better but overall progress was made. This indicates that even when marijuana stocks show trouble trading the industry is doing well.
Ascend Wellness Holdings, Inc. (OTCQX:AAWH) Q1 2025 Results Conference Call May 12, 2025 5:00 PM ET Company Participants Sam Brill - Director and CEO Frank Perullo - Co-Founder, President and Director Roman Nemchenko - Chief Financial Officer Conference Call Participants Frederico Gomes - ATB Capital Markets Andrew Semple - Ventum Financial Neal Gilmer - Haywood Securities Operator Good afternoon, and thank you for standing by. Welcome to Ascend Wellness Holdings First Quarter 2025 Earnings Call.
Ascend Wellness Holdings, Inc. (AAWH) came out with a quarterly loss of $0.09 per share versus the Zacks Consensus Estimate of a loss of $0.08. This compares to loss of $0.09 per share a year ago.
The U.S. cannabis industry is expanding rapidly, with projections suggesting it could surpass $75 billion in value by 2030. This growth is fueled by rising consumer demand, expanding legalization, and increased acceptance of medical cannabis. Recently, lawmakers introduced new legislation that could pave the way for federal cannabis reform. This has reignited investor interest in marijuana-related stocks, especially low-cost options. As the regulatory environment evolves, these penny stocks are drawing attention for their high-reward potential.
The U.S. cannabis industry continues to show impressive growth, making marijuana penny stocks a hot topic for investors this week. In 2024, legal cannabis sales reached over $32 billion across the country. That number is expected to grow past $50 billion by the end of 2025. Many states are expanding access to both medical and recreational marijuana, helping fuel this rapid expansion. In addition, recent discussions around federal reform have renewed optimism. There are growing calls to reschedule cannabis to reflect its medical use. If changes happen, they could unlock major opportunities in the market. Because of this momentum, many investors are turning their attention to low-cost marijuana stocks with high potential.
Marijuana stock investors are working to remain patient as many changes are in the works. At this time there is a heavy amount of speculation on what may happen this year. With Donald Trump as our president legal operators are in fear of facing issues with parts of his staff not in favor of cannabis. Yet nothing major has taken effect just yet. Although volatility is still high in the cannabis sector.
Marijuana stocks are still having issues catching bigger waves of momentum. Even with most cannabis companies reporting strong Q4 earnings it only did so much for the public sector. Many feel as more reform and regulatory issues are met in favor of legal operators it will help the public sector. The biggest fight for legal cannabis is better laws in place that help legal operators, not just corporate cannabis. There are many parts to what makes a strong industry and a solid company.